News
When ocrelizumab became the first FDA-approved treatment for early forms of multiple sclerosis (MS) in 2017, it offered ...
Mitochondrial abnormalities, or problems in cells' powerhouses, contribute to nerve cell death linked to motor control in MS, ...
A study of twins reveals two gut bacteria linked to multiple sclerosis, offering new targets for future treatments.
A trial using PET scans to test the anti-inflammatory drug PIPE-791 finished enrolling healthy volunteers and patients with ...
UC Riverside study may lead to new treatments for multiple sclerosis. Multiple sclerosis (MS) affects an estimated 2.3 ...
UAE doctors warn that summer heat can worsen health issues. People with neurological and cardiovascular diseases are at ...
When surgeons dissect tissue to remove a tumor or make a repair, they must work cautiously, relying on electrophysical ...
Two new biomarkers—the kappa free light chains index and central vein sign—have been added to the McDonald criteria, ...
A team of researchers at Rowan University has developed an injectable biomaterial that could significantly improve recovery ...
Relapsing-remitting MS (RRMS) RRMS is the most common type of the disease. According to the National Multiple Sclerosis Society, about 85% of people with MS have RRMS at the time of diagnosis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results